Loading...
Outcomes of Anti-PD-L1 Therapy With or Without Chemotherapy for First-Line Treatment of Advanced Non-Small Cell Lung Cancer with PD-L1 Score >50%: FDA Pooled Analysis, presented at ASCO 2022 by the Cochin Oncology Group.
June 16, 2022